Avid Bioservices to exit public market with GHO and Ampersand buyout

Pallavi Madhiraju- November 9, 2024 0

In a transformative shift within the biopharmaceutical manufacturing sector, Avid Bioservices, a premier biologics contract development and manufacturing organization (CDMO), has announced its agreement to ... Read More

MilliporeSigma invests over €300m in new South Korean bioprocessing center

Pallavi Madhiraju- March 20, 2024 0

MilliporeSigma, the Life Science business of Merck KGaA, Darmstadt, Germany, in the United States and Canada, has earmarked an investment exceeding €300 million for the ... Read More

Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn

Pallavi Madhiraju- March 20, 2024 0

In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global player in manufacturing for the pharmaceutical, biotech, ... Read More